International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7874475
Original Article
Comparative Study of Corneal Endothelial Changes Among Contact Lens Wearers and Spectacle Users Using Non-Contact Specular Microscopy
 ,
 ,
 ,
Published
April 28, 2023
Abstract
The purpose of this study was to assess the changes in the corneal endothelial cells of medical students and doctors who used soft hydrogel contact lenses for myopia correction during a three-month period. The study included 50 subjects, with 25 wearing contact lenses and the remaining participants wearing spectacles. The morphology of corneal endothelial cells in both groups was assessed using a specular microscope to determine endothelial cell density, coefficient of variation, hexagonality, and central corneal thickness. At baseline (p-value = 0.14) and 3 months (p-value = 0.07), there was no statistically significant difference in refraction between Group A (-2.460.96 diopters) and Group B (-2.831.55 diopters). Similarly, at baseline (p-value = 0.26) or 3 months (p-value = 0.96), there is no statistically significant difference in ECD between Group A (3108.19228.30 cells/mm2) and Group B (3012.53225.95 cells/mm2). Furthermore, p-values larger than 0.05 show no statistically significant difference in COV, HEX, or CCT between the two groups at either time point. The study concluded that the absence of change in corneal endothelial cell shape is most likely attributable to the contact lens material's good oxygen permeability, compliance, and short wearing period.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
652 Views
479 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved